Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1CNS 1

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Thrombosis 1Thromboembolism 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Inflammation 1Immune System Diseases 1Glioma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Dyskinesias 1Duodenal Neoplasms 1Cholangiocarcinoma 1Cardiovascular Diseases 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Temozolomide 16Radiotherapy 7apatinib 5anlotinib 3Surgical Procedures, Operative 3Chlorotoxin 3Bevacizumab 3Aminolevulinic Acid 3Positron Emission Tomography Computed Tomography 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Lomustine 2Irinotecan 2Immunotherapy, Adoptive 2Blood Specimen Collection 2vandetanib 1sodium thiosulfate 1ribociclib 1poly ICLC 1lonafarnib 1lentiviral minigene vaccine of COVID-19 coronavirus 1etoposide phosphate 1Vinblastine 1Valproic Acid 1Tranexamic Acid 1Surveys and Questionnaires 1Sunitinib 1Rivaroxaban 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioma × Rivaroxaban × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡